ARCT
Arcturus Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ARCT Profile
Arcturus Therapeutics Holdings Inc.
A company that developing lipid nanoparticle siRNA drug delivery systems for the orphan disease market
10628 Science Center Drive, Suite 250, San Diego, California 92121
--
Arcturus Therapeutics Holdings Inc., registered in Israel, began operations on February 7, 2008. The company is a global messenger RNA drug company focused on developing infectious disease vaccines and therapies for rare liver and respiratory diseases. The company is leveraging its proprietary LUNAR platform and nucleic acid technology to develop and advance a range of mRNA-based vaccines and therapies for infectious diseases and rare genetic diseases with significant unmet medical needs.